1LIFE HEALTHCARE INC (ONEM) Stock Analyst Earnings Estimates
NASDAQ:ONEM - Nasdaq - US68269G1076 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 276.3M 29.90% | 377.6M 36.66% | 621.552M 64.61% | 1.065B 71.35% | 1.348B 26.57% | 1.675B 24.26% | 1.893B 13.01% | |
| EBITDA YoY % growth | -39.83M -13.64% | -51.63M -29.63% | -198.751M -284.95% | -150.067M 24.50% | -97.31M 35.16% | -59.857M 38.49% | 26.877M 144.90% | |
| EBIT YoY % growth | -54.1M -20.22% | -74M -36.78% | -245.247M -231.41% | -388.186M -58.28% | -309.578M 20.25% | -284.135M 8.22% | N/A | |
| Operating Margin | -19.58% | -19.60% | -39.46% | -36.45% | -22.97% | -16.96% | N/A | |
| EPS YoY % growth | N/A | -0.83 -116.13% | -1.60 -92.77% | -2.09 -30.59% | -1.91 8.77% | -1.62 14.92% | N/A |
All data in USD
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 -7.51% | -0.50 -5.69% | -0.42 11.55% | -0.40 29.85% | -0.48 11.32% | -0.41 17.86% | -0.32 25.53% | -0.33 18.37% | -0.29 40.09% |
| Revenue Q2Q % growth | 280.65M 21.91% | 324.6M 27.74% | 338.59M 32.34% | 345.27M 32.10% | 366.27M 30.51% | 426.71M 31.46% | 435.23M 28.54% | 451.64M 30.81% | 494.86M 35.11% |
| EBITDA Q2Q % growth | -38.919M 21.14% | -25.299M 64.73% | -24.872M 54.56% | -19.57M 61.84% | -24.937M 35.93% | -23.809M 5.89% | -6.492M 73.90% | -6.071M 68.98% | 6.078M 124.37% |
| EBIT Q2Q % growth | -97.247M -1.46% | -88.292M 4.68% | -77.48M 20.46% | -79.285M 32.40% | -59.362M 38.96% | -79.282M 10.21% | -62.202M 19.72% | -63.882M 19.43% | -56.273M 5.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.57 -11.76% | -0.47 | -0.10 | -21.97% |
| Q2 2022 Q2Q % growth | -0.48 -60.00% | -0.49 | 0.01 | 2.56% |
| Q1 2022 Q2Q % growth | -0.47 -62.07% | -0.50 | 0.03 | 6.81% |
| Q4 2021 Q2Q % growth | -0.50 -733.33% | -0.53 | 0.03 | 6.52% |
| Q3 2021 Q2Q % growth | -0.51 -292.31% | -0.26 | -0.25 | -92.83% |
| Q2 2021 Q2Q % growth | -0.30 -25.00% | -0.21 | -0.09 | -46.13% |
| Q1 2021 Q2Q % growth | -0.29 27.50% | -0.15 | -0.14 | -91.51% |
| Q4 2020 Q2Q % growth | -0.06 94.17% | -0.15 | 0.09 | 59.27% |
| Q3 2020 Q2Q % growth | -0.13 | -0.20 | 0.07 | 33.89% |
| Q2 2020 Q2Q % growth | -0.24 | -0.34 | 0.10 | 29.74% |
| Q1 2020 Q2Q % growth | -0.40 | -0.17 | -0.23 | -132.44% |
| Q4 2019 Q2Q % growth | -1.03 | -0.14 | -0.89 | -638.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 261.369M 72.71% | 278.3M | -16.931M | -6.08% |
| Q2 2022 Q2Q % growth | 255.839M 112.46% | 269.67M | -13.831M | -5.13% |
| Q1 2022 Q2Q % growth | 254.102M 112.46% | 251.48M | 2.622M | 1.04% |
| Q4 2021 Q2Q % growth | 230.214M 89.01% | 223.13M | 7.084M | 3.17% |
| Q3 2021 Q2Q % growth | 151.333M 49.10% | 132.74M | 18.593M | 14.01% |
| Q2 2021 Q2Q % growth | 120.416M 59.28% | 117.98M | 2.436M | 2.06% |
| Q1 2021 Q2Q % growth | 119.6M 51.78% | 118.56M | 1.04M | 0.88% |
| Q4 2020 Q2Q % growth | 121.8M 57.36% | 108.76M | 13.04M | 11.99% |
| Q3 2020 Q2Q % growth | 101.5M 45.83% | 87.906M | 13.594M | 15.46% |
| Q2 2020 Q2Q % growth | 75.6M 14.20% | 62.955M | 12.645M | 20.09% |
| Q1 2020 Q2Q % growth | 78.8M 25.08% | 76.503M | 2.297M | 3.00% |
| Q4 2019 Q2Q % growth | 77.4M | 77.665M | -265K | -0.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -8.04% |
| Revenue | 0% | -0.34% | 0% | -2.29% |